Related Experiment Videos
Rising PSA after local therapy failure: immediate vs deferred treatment
1Department of Surgery, Walter Reed Army Medical Center, Washington, DC, USA.
Oncology (Williston Park, N.Y.)
|August 12, 1999
Summary
Predicting prostate cancer recurrence after surgery is improving with new models. These models use traditional factors and molecular biomarkers to guide treatment decisions for rising PSA levels.
Area of Science:
- Urology
- Oncology
- Medical Statistics
Background:
- Rising prostate-specific antigen (PSA) levels after initial prostate cancer treatment, known as PSA-only recurrence, is increasingly common.
- Accurate prediction of recurrence is crucial for effective patient management.
Purpose of the Study:
- To develop and evaluate predictive models for PSA-only recurrence after radical prostatectomy.
- To identify optimal treatment strategies for patients experiencing PSA-only recurrence.
Main Methods:
- Development of two predictive models: one using traditional factors (race, PSA, Gleason sum, organ confinement) and another incorporating molecular biomarkers.
- Analysis of treatment outcomes for observation, radiation therapy, salvage surgery, cryotherapy, and hormonal therapy.
Main Results:
- The study presents two models to predict PSA-only recurrence post-prostatectomy.
- Radiation therapy shows benefit for specific patient subgroups (no adverse pathology, low PSA, late recurrence).
- Salvage surgery and cryotherapy carry significant risks and require careful patient selection.
Conclusions:
- Predictive models incorporating molecular biomarkers may improve recurrence prediction.
- Hormonal therapy is a key treatment for PSA-only recurrence, with novel approaches under investigation.
- Further clinical trials are necessary to refine prognostic models and optimize treatment strategies.